All of the following are true about antiglaucoma drugs except
Brimonidine & apraclonidine are unsafe in infants as they can cross BBB and depress central nervous system.
PGF2 α analogues increase uveoscleral outflow
Usage of Timolol is unsafe in infants
Apraclonidine can lead to lid retraction
Adrenaline can lead to conjuctival pigmentation